ATTENUATION OF COLITIS BY ORAL DELIVERY OF BACTERIAL-MEDIATED RNAI TARGETING TNF ALPHA

(1) Research

(2) Development, Cequent Pharmaceuticals, Cambridge, United States



This item was part of the Anti TNF therapy in IBD: Current to future session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A70